US healthcare clients are desperate to cut costs and therefore, there cannot be a better time than today to buy TriZetto, says Gordon Coburn, President, Cognizant.
Cognizant on Monday said it will acquire US-based TriZetto Corporation for USD 2.7 billion in an all cash big-ticket deal, a move that will help the IT services firm tap the lucrative healthcare IT software and solutions market for revenue synergies.
Speaking to CNBC-TV18, Gordon Coburn, President, Cognizant said revenues from TriZetto will add to incremental guidance, no matter how big or small. “TriZetto’s margins are comparable to us; this is a topline play,” he says.
He expects TriZetto deal to close by Q4 of the current fiscal along with all regulatory approvals.”US healthcare clients are desperate to cut costs and therefore, there cannot be a better time than today to buy TriZetto,” he told the channel.
Cognizant-TriZetto combine can compete for larger deals, adds Coburn. Experts too believe that in terms of grabbing the healthcare pie, the firm may race ahead of Accenture, IBM, EMC and Capgemini, if the deal goes through.
Transcript to follow shortly